{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial Comparing Rubber Band Ligation and Hemorrhoidectomy for Grade III Hemorrhoids"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This multicenter, open-label, parallel-group, randomised controlled noninferiority trial was conducted across 10 hospitals in the Netherlands."
      },
      "Participants": {
        "score": 2,
        "evidence": "Adults with symptomatic grade III hemorrhoids were eligible. Exclusion criteria included prior rectal/anal surgery and medical unfitness."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised 1:1 to RBL or hemorrhoidectomy."
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial compares the effectiveness of rubber band ligation (RBL) and hemorrhoidectomy."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcomes were 12-month health-related quality of life (HR-QoL) and recurrence rate."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was web-based with allocation concealment."
      },
      "Blinding": {
        "score": 0,
        "evidence": "No blinding was applied."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Eighty-seven patients were randomised (47 RBL, 40 hemorrhoidectomy) from October 2019 to September 2022."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 46 RBL and 33 hemorrhoidectomy patients."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "RBL was not noninferior to hemorrhoidectomy in HR-QoL (mean difference -0.045; 95% CI, -0.087 to -0.004). Recurrence was higher in the RBL group (48.8% vs 6.1%; absolute risk difference 43%, 95% CI, 25%-60%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were comparable, with 6% in the RBL group and 12% in the hemorrhoidectomy group experiencing complications."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT04621695."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}